IGFBP7 and acute kidney injury: The NephroCheck test serves as a diagnostic tool that measures urinary levels of IGFBP7 and TIMP2 to quantify early kidney stress, offering clinicians a valuable predictive measure of AKI risk within 12-48 hours before kidney injury becomes clinically detectable.